We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 May 2024) launched AI Airlock, its new regulatory sandbox for AI as a Medical Device (AIaMD).
Analysts from the Accelerated Capability Environment (ACE) help increase knowledge to inform future policymaking.
HMS Trent recently seized drugs after making two interceptions while on patrol
Guidance for manufacturers who don’t design or manufacture devices but place their names on the product.
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm.
This guide is about infections that occur in people who inject drugs (PWID).
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
HMS Lancaster seizes almost £33 million worth of drugs in the Middle East.
A summary of recent letters and notifications sent to healthcare professionals about medicines.
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to pink discolouration of the dacarbazine solution immediately after reconstitution (after correct preparation and storage).
Find alerts and recalls issued by MHRA
The review will examine the harm that drugs cause and look at prevention, treatment and recovery.
Department of Health and Social Care and MHRA register of electronic export certificates (human).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).